Antibodies of AGO2


1 antibodies are included.     

 Released    NotSatisfied    Submitted    NotReviewed    OnHold    Submitting    Experimented   
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
AGO2Product_ID: H00027161-M01
Lot_ID: E8251-S2
Source: Abnova
Target Name: AGO2-human		 AGO2_HepG2.png<br>Caption: IP-Western Blot analysis of HepG2 whole cell lysate using AGO2/EIF2C2 specific antibody. Lane 1 is 2% of ten million whole cell lysate input (lane under '10% input') , lane 2 is 20% of IP enrichment using mouse normal IgG (lane under 'IgG') and lane 3 is 20% IP enrichment using mouse monoclonal anti-AGO2/EIF2C2 antibody (lanes under 'anti-AGO2'). Asterisk indicates heavy and light chains of antibody.
 AGO2-HEPG2_FU's.png<br>Caption: Western blot following CRISPR against AGO2 in HepG2 whole cell lysate using AGO2 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against AGO2. AGO2 protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.
 AGO2_K562.png<br>Caption: IP-Western Blot analysis of K562 whole cell lysate using AGO2/EIF2C2 specific antibody. Lane 1 is 2% of ten million whole cell lysate input (lane under '10% input') , lane 2 is 20% of IP enrichment using mouse normal IgG (lane under 'IgG') and lane 3 is 20% IP enrichment using mouse monoclonal anti-AGO2/EIF2C2 antibody (lanes under 'anti-AGO2'). Asterisk indicates heavy and light chains of antibody.